Lantheus Holdings (LNTH) Amortization - Deferred Charges (2016)
Lantheus Holdings (LNTH) reported Amortization - Deferred Charges of $368000.0 for Q4 2016, down 73.99% quarter-over-quarter from $1.4 million in Q3 2016.
Lantheus Holdings (LNTH) Amortization - Deferred Charges (2016) Analysis & Trends
Lantheus Holdings (LNTH) has 1 years of Amortization - Deferred Charges data on file, last reported at $368000.0 in Q4 2016.
- Amortization - Deferred Charges for Q4 2016 came in at $368000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $1.8 million (changed N/A YoY), and the FY2016 annual result was $1.6 million, changed N/A from the prior year.
- Amortization - Deferred Charges slipped to $368000.0 in Q4 2016 per LNTH's latest filing, from $1.4 million in the prior quarter.
- Over five years, Amortization - Deferred Charges peaked at $1.4 million in Q3 2016 and troughed at $368000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 368,000.00 |
| Dec 31, 2016 | 368,000.00 |
| Sep 30, 2016 | 1.42 Mn |
| Sep 30, 2016 | 1.42 Mn |